These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2782438)

  • 41. Effects of neuropeptide Y on the pressor responses to phenylephrine and to activation of the sympathetic nervous system in anaesthetized rats.
    Revington ML; McCloskey DI; Potter EK
    Clin Exp Pharmacol Physiol; 1987 Sep; 14(9):703-10. PubMed ID: 3442953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity.
    Zhang K; Mayhan WG; Patel KP
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R864-72. PubMed ID: 9321861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of renal sympathetic outflow by intracisternal hypertonic NaCl in dogs.
    Abe I; Averill DB; Ferrario CM
    Am J Physiol; 1989 Feb; 256(2 Pt 2):H411-6. PubMed ID: 2644846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biphasic blood pressure response to neuropeptide Y in anesthetized rats.
    Grundemar L; Wahlestedt C; Shen GH; Zukowska-Grojec Z; Håkanson R
    Eur J Pharmacol; 1990 Apr; 179(1-2):83-7. PubMed ID: 2364989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats.
    Lin Y; Matsumura K; Fukuhara M; Kagiyama S; Fujii K; Iida M
    Hypertension; 2004 May; 43(5):977-82. PubMed ID: 14993197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: relationship with noradrenaline and vasopressin.
    Carter DA; Vallejo M; Lightman SL
    Peptides; 1985; 6(3):421-5. PubMed ID: 3840887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P
    Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit.
    Minson R; McRitchie R; Chalmers J
    J Auton Nerv Syst; 1989 Jul; 27(2):139-46. PubMed ID: 2550538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholinergic activation of neurons in the medulla oblongata changes urinary bladder activity by plasma vasopressin release in female rats.
    Cafarchio EM; da Silva LA; Auresco LC; Ogihara CA; Almeida RL; Giannocco G; Luz MC; Fonseca FL; Sato MA
    Eur J Pharmacol; 2016 Apr; 776():116-23. PubMed ID: 26879866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DMPP-evoked increases in postganglionic sympathetic nerve activity and blood pressure occurs by two mechanisms in the rat.
    Martin JR
    J Auton Pharmacol; 1997 Aug; 17(4):249-59. PubMed ID: 9373784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats.
    Kashihara K; McMullan S; Lonergan T; Goodchild AK; Pilowsky PM
    Auton Neurosci; 2008 Nov; 142(1-2):64-70. PubMed ID: 18573695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of intracerebral injection of neuropeptide Y in rats.
    Yang SN; Yang W; Tang YH; Wang S
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):116-8. PubMed ID: 1598826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.